Friday, August 18, 2017
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at page facebook
American Academy of Ophthalmology Statement on Stem Cell Therapy for Treating Eye Disease
(March 20, 2017)

SAN FRANCISCO, March 20, 2017 /PRNewswire-USNewswire/ -- A recent article in the New England Journal of Medicine highlights concerns that the American Academy of Ophthalmology has previously expressed regarding stem cell therapy for diseases of the retina. 

In June 2016 the Academy issued clinical guidance that covers the appropriate use of stem cell therapy in eye care.   An article co-authored by the Academy's Chief Executive Officer in the November issue of the Academy's journal Ophthalmology highlights the dangers of unapproved trials, the need for appropriate oversight, and the risk to patients looking for a transformative cure. 

The Academy has called on both the National Institutes of Health and the U.S. Food and Drug Administration to take steps to better ensure public safety associated with treatments outside of FDA-approved clinical trials.  Good research is being performed under FDA-approved trials by innovative clinician-scientists and tragedy associated with non-approved use of stem cells threatens the conduct and impact of this high-quality science.

The public and patients can learn more about stem cells and eye care by visiting the Academy's EyeSmart® public education website. EyeSmart is the leading online source for ophthalmic information. The content is written and approved by Academy member eye physicians and surgeons.

About the American Academy of Ophthalmology
The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit

To view the original version on PR Newswire, visit:

SOURCE American Academy of Ophthalmology

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:England, USA, Medicine, Disease, Surgery, Medication, Science, Medical, Biology, Stem Cell, Science, england,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • HeadAid Products Soon to be Available on
  • Ascension Teams with Plug and Play Tech Center to Connect with Health and Wellness Startups
  • Global Sleep Apnea Devices Market to Grow at a CAGR of 7.8% by 2024 - Large Scale Benefits of Medical Devices is Driving Demand for Medical Platforms.
  • At 8+% CAGR Lateral Flow Assay Market Potentially Worth $8.24 Billion by 2022 Led by Asia-Pacific Region
  • UNITY Biotechnology Announces Extension of Series B Financing Bringing Total Round to $151 Million

  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
  • ASPCA and the Petco Foundation Partner to Grant $1.5 Million to Dogs Playing For Life to Expand Life-Saving Playgroups Nationwide
  • United States Pain Management Therapeutics Market, Patients Volume, and 50 Companys Pipeline Analysis (By Product, Indication, Phase of Development)

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines